Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Orbimed Capital Gp Vi Llc
Relationship:   Director, 10% Owner
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   17    
Direct Shares   5,826,224    

Indirect Shares

   46,949,846      
Direct Value   $176,884,161    

Indirect Value

   $508,271,559      
Total Shares   52,776,070      
Total Value   $685,155,720      


Disc Medicine, Inc $176,884,161 Disc Medicine, Inc $176,884,161
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    16    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    16    
   
     Gain/Loss Ratio :
   0.0   
   -16.0   
     Percentage Gain/Loss :
     0.0%
 -577.9%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synlogic Inc SYBX Director 0 2021-04-20 3,696,662    Premium*  
            Kala Pharmaceuticals, Inc. KALA 10% Owner 2018-01-12 0 2018-02-08 3,447,840    Premium*  
            Adicet Bio, Inc ACET Director, 10% Owner 2018-01-30 0 2018-01-30 4,830,387    Premium*  
            Constellation Pharmaceuticals Inc CNST 10% Owner 2018-07-23 0 2018-07-23 417,921    Premium*  
            Alpine Immune Sciences Inc ALPN Director, 10% Owner 2019-01-18 0 2020-12-28 3,070,955    Premium*  
            Turning Point Therapeutics, Inc. TPTX Director 2019-04-22 0 2019-04-22 2,027,550    Premium*  
            Nextcure, Inc. NXTC Director, 10% Owner 2019-05-13 0 2019-05-13 2,711,013    Premium*  
            Prevail Therapeutics Inc. PRVL Director, 10% Owner 0 2021-01-22 0    Premium*  
            Springworks Therapeutics, Inc. SWTX 10% Owner 2019-09-17 0 2022-09-12 5,599,842    Premium*  
            Cti Biopharma Corporation CTIC 10% Owner 0 2021-01-07 7,520,600    Premium*  
            Oric Pharmaceuticals, Inc. ORIC Director 2020-04-24 0 2021-03-30 2,212,571    Premium*  
            Prelude Therapeutics Inc PRLD Director, 10% Owner 0 2020-09-24 206,912    Premium*  
            Calcimedica Ord Shs CALC 10% Owner 2020-09-25 0 2020-09-29 4,163,347    Premium*  
            Silverback Therapeutics, Inc. SBTX Director, 10% Owner 0 2020-12-03 538,646    Premium*  
            Disc Medicine, Inc IRON Director, 10% Owner 2021-02-05 5,826,224 0    Premium*  
            Neuropace Inc NPCE 10% Owner 2021-04-21 0 2024-05-03 3,406,335    Premium*  
            Turnstone Biologics Corp. TSBX Director, 10% Owner 2023-07-20 0 2023-07-20 3,099,265    Premium*  
* Premium Members only  

Records found :    84         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-12 4 B $14.50 $556,133 I/I 38,354 2,731,069 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-19 4 B $14.95 $1,120,218 I/I 74,931 2,806,000 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-22 4 B $14.98 $1,123,500 I/I 75,000 2,881,000 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-23 4 B $14.99 $65,401 I/I 4,363 2,885,363 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-24 4 B $14.91 $963,738 I/I 64,637 2,950,000 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-26 4 B $14.93 $339,807 I/I 22,760 2,972,760 1.5 -
SYBX Synlogic Inc Director   –       •      –    2018-01-26 4 A $9.75 $6,971,250 I/I 715,000 2,029,996 0 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-29 4 B $14.99 $749,500 I/I 50,000 3,022,760 1.5 -
ACET Adicet Bio, Inc Director   –       •       •   2018-01-30 4 B $15.00 $7,999,995 I/I 533,333 4,830,387 2.25 -
ACET Adicet Bio, Inc Director   –       •       •   2018-01-30 4 A $0.00 $0 I/I 4,297,054 4,297,054 0 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-01-31 4 B $15.00 $5,091,000 I/I 339,400 3,362,160 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-02-01 4 B $14.99 $342,372 I/I 22,840 3,385,000 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-02-02 4 B $14.73 $557,383 I/I 37,840 3,422,840 1.5 -
KALA Kala Pharmaceuticals, Inc... 10% Owner   –       –       •   2018-02-08 4 B $12.93 $323,250 I/I 25,000 3,447,840 1.5 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2018-07-23 4 A $0.00 $0 I/I 635,842 317,921 0 -
CNST Constellation Pharmaceuti... 10% Owner   –       –       •   2018-07-23 4 B $15.00 $3,000,000 I/I 200,000 417,921 1.5 -
ALPN Alpine Immune Sciences In... Director   –       •       •   2019-01-18 4 B $5.37 $1,999,997 I/I 372,439 3,670,955 2.25 -
TPTX Turning Point Therapeutic... Director   –       •      –    2019-04-22 4 A $0.00 $0 I/I 1,667,550 1,667,550 0 -
TPTX Turning Point Therapeutic... Director   –       •      –    2019-04-22 4 B $18.00 $6,480,000 I/I 360,000 2,027,550 2.1 -
NXTC Nextcure, Inc. Director   –       •       •   2019-05-13 4 A $0.00 $0 I/I 2,361,013 2,361,013 0 -
NXTC Nextcure, Inc. Director   –       •       •   2019-05-13 4 B $15.00 $5,250,000 I/I 350,000 2,711,013 2.25 -
PRVL Prevail Therapeutics Inc. Director   –       •       •   2019-06-24 4 B $17.00 $14,999,984 I/I 882,352 13,822,463 2.25 -
PRVL Prevail Therapeutics Inc. Director   –       •       •   2019-06-24 4 A $0.00 $0 I/I 10,510,111 12,940,111 0 -
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2019-09-17 4 A $0.00 $0 I/I 7,131,307 7,131,307 0 -
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2019-09-17 4 B $18.00 $4,950,000 I/I 275,000 7,406,307 1.5 -
  84  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us